SAMHD1 and acute myeloid leukemia: THP-1 AML cells, in which the SAMHD1 gene was disrupted using CRISPR/Cas9 (THP-1 KO cells), displayed increased CNDAC sensitivity (Fig. 2A) and CNDAC-TP levels (Fig. 2B) relative to control cells.